Human Herpesvirus 6 Infection after Hematopoietic Cell Transplantation: Is Routine Surveillance Necessary?

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 10, 2011, Pages 1562-1568

  Betts, Brian C ^a   Young, Jo Anne H ^a,b   Ustun, Celalettin ^a,b   Cao, Qing ^b   Weisdorf, Daniel J ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Allogeneic transplantation; Foscarnet; Ganciclovir; Human herpesvirus 6; Umbilical cord blood

Indexed keywords

ACICLOVIR; CIDOFOVIR; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; FOSCARNET; GANCICLOVIR; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; VALGANCICLOVIR;

ACUTE GRAFT VERSUS HOST DISEASE; ADD ON THERAPY; ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIVIRAL THERAPY; ARTICLE; BONE MARROW SUPPRESSION; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE SURVEILLANCE; DRUG MEGADOSE; ENGRAFTMENT SYNDROME; FEMALE; FEVER; GRAFT VERSUS HOST REACTION; HEPATITIS; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OBSERVATIONAL STUDY; PNEUMONIA; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PROSPECTIVE STUDY; QUANTITATIVE ASSAY; RASH; REDUCED INTENSITY CONDITIONING; SCHOOL CHILD; SURVIVAL; UMBILICAL CORD BLOOD; VIREMIA; VIRUS REACTIVATION; WHOLE BODY RADIATION;

ADULT; AGED; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS INFECTIONS; DISEASE-FREE SURVIVAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPESVIRUS 6, HUMAN; HUMANS; INFANT; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; ROSEOLOVIRUS INFECTIONS; SEX FACTORS; SIBLINGS; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS; UNRELATED DONORS; VIREMIA;

EID: 80052963869     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2011.04.004     Document Type: Article

References (49)

1. Zerr D.M., Meier A.S., Selke S.S., et al. A population-based study of primary human herpesvirus 6 infection. N Engl J Med 2005, 352:768-776.
2. Campadelli-Fiume G., Mirondaol P., Menoti L. Human Herpesvirus 6: an emerging pathogen. Emerg Infect Dis 1999, 5:353-366.
3. Kadakia M.P., Rybka W.B., Stewart J.A., et al. Human herpesvirus 6: infection and disease following autologous and allogeneic bone marrow transplantation. Blood 1996, 87:5341-5354.
4. Imbert-Marcille B.M., Tang X.W., Lepelletier D., et al. Human herpesvirus 6 infection after autologous or allogeneic stem cell transplantation: a single-center prospective longitudinal study of 92 patients. Clin Infect Dis 2000, 31:881-886.
5. Zerr D.M., Corey L., Kim H.W., Huang M.L., Nguy L., Boeckh M. Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. Clin Infect Dis 2005, 40:932-940.
6. Reddy S., Manna P. Quantitative detection and differentiation of human herpesvirus 6 subtypes in bone marrow transplant patients by using a single real-time polymerase chain reaction assay. Biol Blood Marrow Transplant 2005, 11:530-541.
7. Ihira M., Yoshikawa T., Suzuki K., et al. Monitoring of active HHV-6 infection in bone marrow transplant recipients by real time PCR; comparison to detection of viral DNA in plasma by qualitative PCR. Microbiol Immunol 2002, 46:701-705.
8. Hentrich M., Oruzio D., Jager G., et al. Impact of human herpesvirus-6 after haematopoietic stem cell transplantation. Br J Haematol 2005, 128:66-72.
9. Yoshikawa T., Asano Y., Ihira M., Suzuki K., Ohashi M., et al. Human herpesvirus 6 viremia in bone marrow transplant recipients: clinical features and risk factors. J Infect Dis 2002, 185:847-853.
10. Ogata M., Kikuchi H., Satou T., et al. Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance. J Infect Dis 2006, 193:68-79.
11. Yamane A., Mori T., Suzuki S., et al. Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders. Biol Blood Marrow Transplant 2007, 13:100-106.
12. Ljungman P., Wang F.Z., Clark D.A., et al. High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients. Br J Haematol 2000, 111:774-781.
13. Radonic A., Oswald O., Thulke S., et al. Infections with human herpesvirus 6 variant B delay platelet engraftment after allogeneic haematopoietic stem cell transplantation. Br J Haematol 2005, 131:480-482.
14. Tomonari A., Takahashi S., Ooi J., et al. Human herpesvirus 6 variant A infection with fever, skin rash, and liver dysfunction in a patient after unrelated cord blood transplantation. Bone Marrow Transplant 2005, 36:1109-1110.
15. Chevallier P., Hebia-Fellah I., Planche L., et al. Human herpes virus 6 infection is a hallmark of cord blood transplant in adults and may participate to delayed engraftment: a comparison with matched unrelated donors as stem cell source. Bone Marrow Transplant 2010, 45:1204-1211.
16. Ogata M., Satou T., Kawano R., et al. Plasma HHV-6 viral load-guided preemptive therapy against HHV-6 encephalopathy after allogeneic stem cell transplantation: a prospective evaluation. Bone Marrow Transplant 2008, 41:279-285.
17. Zerr D.M., Gupta D., Huang M.L., Carter R., Corey L. Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002, 34:309-317.
18. Fujimaki K., Mori T., Kida A., et al. Human herpesvirus 6 meningoencephalitis in allogeneic hematopoietic stem cell transplant recipients. Int J Hematol 2006, 84:432-437.
19. Wainwright M.S., Martin P.L., Morse R.P., Lacaze M., Provenzale J.M., et al. Human herpesvirus 6 limbic encephalitis after stem cell transplantation. Ann Neurol 2001, 50:612-619.
20. Vu T., Carrum G., Hutton G., Heslop H.E., Brenner M.K., et al. Human herpesvirus-6 encephalitis following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2007, 39:705-709.
21. Chamberlain M.C., Chowdhary S. Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6. Neurology 2008, 70:491-492.
22. Wang F.Z., Linde A., Hagglund H., Testa M., Locasciulli A., Ljungman P. Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: does it have clinical significance?. Clin Infect Dis 1999, 28:562-568.
23. Drobyski W.R., Knox K.K., Majewski B.S., Carrigan D.R. Brief report: fatal encephalitis due to variant B human herpesvirus 6 in a bone marrow transplant recipient. N Engl J Med 1994, 330:1356-1360.
24. Cone R.W., Huang M.L., Corey L., Zeh J., Ashley R., Bowden R. Human herpesvirus 6 infections after bone marrow transplantation: clinical and virologic manifestations. J Infect Dis 1999, 179:311-318.
25. Sashihara J., Tanaka-Taya K., Tanaka S., et al. High incidence of human herpesvirus 6 infection with a high viral load in cord blood stem cell transplant recipients. Blood 2002, 100:2005-2011.
26. Yoshikawa T., Suga S., Asano Y., et al. Human herpesvirus-6 infection in bone marrow transplantation. Blood 1991, 78:1381-1384.
27. Volin L., Lautenschlager I., Juvonen E., Nihtinen A., Anttila V.J., Ruutu T. Human herpesvirus 6 antigenaemia in allogeneic stem cell transplant recipients: impact on clinical course and association with other betaherpesviruses. Br J Haematol 2004, 126:690-696.
28. Tomonari A., Takahashi S., Ooi J., et al. Human herpesvirus 6 variant B infection in adult patients after unrelated cord blood transplantation. Int J Hematol 2005, 81:352-355.
29. Cone R.W., Hackman R.C., Huang M.L., et al. Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation. N Engl J Med 1993, 329:156-161.
30. Carrigan D.R., Drobyski W.R., Russler S.K., Tapper M.A., Knox K.K., Ash R.C. Interstitial pneumonitis associated with human herpesvirus-6 infection after marrow transplantation. Lancet 1991, 338:147-149.
31. Buchbinder S., Elmaagacli A.H., Schaefer U.W., Roggendorf M. Human herpesvirus 6 is an important pathogen in infectious lung disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 2000, 26:639-644.
32. Pereira C.M., de Almeida O.P., Correa M.E., Costa F.F., de Souza C.A., Barjas-Castro M.L. Detection of human herpesvirus 6 in patients with oral chronic graft-vs-host disease following allogeneic progenitor cell transplantation. Oral Dis 2007, 13:329-334.
33. de Pagter P.J., Schuurman R., Meijer E., van Baarle D., Sanders E.A., Boelens J.J. Human herpesvirus type 6 reactivation after haematopoietic stem cell transplantation. J Clin Virol 2008, 43:361-366.
34. de Pagter P.J., Schuurman R., Visscher H., et al. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome. Biol Blood Marrow Transplant 2008, 14:831-839.
35. Ljungman P., de la Camara R., Cordonnier C., et al. Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT. Bone Marrow Transplant 2008, 42:227-240. European Conference on Infections in Leukemia.
36. Walker C.M., van Burik J.A., De For T.E., Weisdorf D.J. Cytomegalovirus infection after allogeneic transplantation: comparison of cord blood with peripheral blood and marrow graft sources. Biol Blood Marrow Transplant 2007, 13:1106-1115.
37. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-481.
38. Boutolleau D., Fernandez C., Andre E., et al. Human herpesvirus-6 and HHV-7: two closely related viruses with different infection profiles in stem cell transplantation recipients. J Infect Dis 2003, 187:179-186.
39. Weinberg A., Enomoto L., Li S., Shen D., Coll J., Shpall E.J. Risk of transmission of herpesviruses through cord blood transplantation. Biol Blood Marrow Transplant 2005, 11:35-38.
40. Adams O., Krempe C., Kogler G., Wernet P., Scheid A. Congenital infections with human herpesvirus 6. J Infect Dis 1998, 178:544-546.
41. Daibata M., Miyoshi I. Presence of human herpesvirus 6 DNA in cord blood cells. J Infect Dis 1999, 179:1046-1047.
42. Tormo N., Solano C., de la Cámara R., et al. An assessment of the effect of human herpesvirus-6 replication on active cytomegalovirus infection after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2010, 16:653-661.
43. Humar A., Malkan G., Moussa G., Greig P., Levy G., Mazzulli T. Human herpesvirus-6 is associated with cytomegalovirus reactivation in liver transplant recipients. J Infect Dis 2000, 181:1450-1453.
44. Brown J., Boussiotis V.A. Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstituion. Clin Immunol 2008, 127:286-297.
45. Szabolcs P., Niedzwiecki D. Immune reconstitution in children after unrelated cord blood transplantation. Cytotherapy 2007, 9:111-122.
46. Trivedi H.N., Hay Glass K.T., Gangur V., Allardice J.G., Embree J.E., Plummer F.A. Analysis of neonatal T cell and antigen presenting cell functions. Hum Immunol 1997, 57:69-79.
47. Walker C.M., van Burik J.A., De For T.E., Weisdorf D.J. Cytomegalovirus infection after allogeneic transplantation: comparison of cord blood with peripheral blood and marrow graft sources. Biol Blood Marrow Transplant 2007, 13:1106-1115.
48. Beck J.C., Wagner J.E., DeFor T.E., et al. Impact of cytomegalovirus (CMV) reactivation after umbilical cord blood transplantation. Biol Blood Marrow Transplant 2010, 16:215-222.
49. Zerr D.M., Gupta D., Huang M.L., Carter R., Corey L. Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002, 34:309-317.